Point72 Asset Management
PTX

Point72 Asset Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Point72 Asset Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-250,000
Closed -$2.63M – 961
2016
Q1 		$2.63M Buy
250,000
+144,999
+138% +$2.88M 0.02% 532
2015
Q4 		$3.1M Hold
105,001
– – 0.03% 490
2015
Q3 		$3.32M Buy
105,001
+52,501
+100% +$2.51M 0.03% 488
2015
Q2 		$3.11M Buy
+52,500
New +$3.7M 0.02% 526

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Point72 Asset Management's PTX Position: Q2 2016 in Review

Point72 Asset Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 250,000 shares — an estimated $2.63M sold.

Point72 Asset Management first reported a position in PTX in Q2 2015 and held it in 4 quarters. The position peaked at $3.32M in Q3 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • Point72 Asset Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Point72 Asset Management sold 250,000 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $2.63M.
  • Point72 Asset Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2015 and held it in 4 quarters.
  • Point72 Asset Management's Pernix Therapeutics Holdings, Inc. position peaked at $3.32M in Q3 2015.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Point72 Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.